cystathionine gamma-lyase deficiency mediates neurodegeneration huntingtons disease 
huntingtons disease autosomal dominant disease associated mutation gene encoding huntingtin htt leading expanded polyglutamine repeats mutant htt mhtt elicit oxidative stress neurotoxicity motor behavioural changes huntingtons disease characterized highly selective profound damage corpus striatum regulates motor function striatal selectivity huntingtons disease may reflect striatally selective small g protein rhes binding mhtt enhancing neurotoxicity specific molecular mechanisms mhtt elicits neurodegeneration hard determine show major depletion cystathionine gamma-lyase cse biosynthetic enzyme cysteine huntingtons disease tissues may mediate huntingtons disease pathophysiology defect occurs transcriptional level seems reflect influences mhtt specificity protein transcriptional activator cse consistent notion loss cse pathogenic mechanism supplementation cysteine reverses abnormalities cultures huntingtons disease tissues intact mouse models huntingtons disease suggesting therapeutic potential 
